Fritz et al. elucidated that RUNX1 and RUNX2 have divergent effects on breast cancer stem cells; specifically, the downregulation of RUNX1 accompanied by RUNX2 upregulation fosters EMT and sustains stem cell-like properties [128]. This evidence concerns the gene RUNX1 and breast cancer.